This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Giovannoni, G Articles by Thompson, E J Search for Related Content PubMed PubMed Citation Articles by Giovannoni, G Articles by Thompson, E J Social Bookmarking                   What's this?

The potential role of nitric oxide in multiple sclerosis

Neuroimmunology Unit, Institute of Neurology, Queen Square, London WC1N 3BG

S J.R. Heales

Department of Clinical Biochemistry, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG

J M Land

Department of Clinical Biochemistry, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG

E J Thompson

Department of Neuroimmunology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, Neuroimmunology Unit, Institute of Neurology, Queen Square, London WC1N 3BG

Nitric oxide (.NO) and its reactive derivative peroxynitrite (ONOO⁷) have been implicated in the pathogenesis of multiple sclerosis (MS). They are cytotoxic to oligodendrocytes and neurones in culture by inhibiting the mitochondrial respiratory chain (complexes II/III and IV) and inhibiting certain key intracellular enzymes. Recently .NO has been implicated as a possible aetiological factor in reversible conduction block in demyelinated axons. Inducible nitric oxide synthase (iNOS) is upregulated in the central nervous system of animals with experimental allergic encephalomyelitis (EAE) and in patients with MS. In some EAE models inhibiting iNOS activity decreases disease severity whilst in other models disease activity is exacerbated. Raised levels of nitrate and nitrite, stable end-products of .NO/ONOO⁷, are found in the cerebrospinal fluid, serum and urine of patients with MS. CSF levels of nitrate and nitrite correlate with blood-brain-barrier dysfunction, which suggests that .NO may play a role in inflammatory blood-brain-barrier dysfunction. In a longitudinal study on 24 patients with relapsing remitting and secondary progressive MS, raised serum nitrate and nitrite levels correlated with a relapsing course and infrequent relapses. However, no correlation was found between raised serum levels of nitrate and nitrite and MRI activity, disease progression, or the development of cerebral atrophy. In autoimmune mediated CNS demyelinating disease .NO may be a double-edged sword, mediating tissue damage on the one hand and on the other hand modulating complex immunological functions which may be protective.

Key Words: multiple sclerosis • nitric oxide • nitrate • nitrite • nitric oxide synthase

Multiple Sclerosis, Vol. 4, No. 3, 212-216 (1998)
DOI: 10.1177/135245859800400323


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]

				C. Rozenfeld, R. Martinez, S. Seabra, C. Sant'Anna, J. G. R. Goncalves, M. Bozza, V. Moura-Neto, and W. De Souza Toxoplasma gondii Prevents Neuron Degeneration by Interferon-{gamma}-Activated Microglia in a Mechanism Involving Inhibition of Inducible Nitric Oxide Synthase and Transforming Growth Factor-{beta}1 Production by Infected Microglia Am. J. Pathol., October 1, 2005; 167(4): 1021 - 1031. [Abstract] [Full Text] [PDF]

				A. S. Paintlia, M. K. Paintlia, M. Khan, T. Vollmer, A. K. Singh, and I. Singh HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis FASEB J, September 1, 2005; 19(11): 1407 - 1421. [Abstract] [Full Text] [PDF]

				X. Liu, C. Ciumas, Y.-M. Huang, K. R Steffensen, H. Lian, H. Link, and B.-G. Xiao Autoantigen-pulsed dendritic cells constitute a beneficial cytokine and growth factor network in ameliorating experimental allergic encephalomyelitis Multiple Sclerosis, August 1, 2005; 11(4): 381 - 389. [Abstract] [PDF]

				S. E. Baranzini, C. C. A. Bernard, and J. R. Oksenberg Modular Transcriptional Activity Characterizes the Initiation and Progression of Autoimmune Encephalomyelitis J. Immunol., June 1, 2005; 174(11): 7412 - 7422. [Abstract] [Full Text] [PDF]

				C. Rozenfeld, R. Martinez, R. T. Figueiredo, M. T. Bozza, F. R. S. Lima, A. L. Pires, P. M. Silva, A. Bonomo, J. Lannes-Vieira, W. De Souza, et al. Soluble Factors Released by Toxoplasma gondii-Infected Astrocytes Down-Modulate Nitric Oxide Production by Gamma Interferon-Activated Microglia and Prevent Neuronal Degeneration Infect. Immun., April 1, 2003; 71(4): 2047 - 2057. [Abstract] [Full Text]

				J. S.-H. Liu, M.-L. Zhao, C. F. Brosnan, and S. C. Lee Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions Am. J. Pathol., June 1, 2001; 158(6): 2057 - 2066. [Abstract] [Full Text] [PDF]

				L.-Y. Xu, J.-S. Yang, H. Link, and B.-G. Xiao SIN-1, a Nitric Oxide Donor, Ameliorates Experimental Allergic Encephalomyelitis in Lewis Rats in the Incipient Phase: The Importance of the Time Window J. Immunol., May 1, 2001; 166(9): 5810 - 5816. [Abstract] [Full Text] [PDF]